5 patents
Utility
Composition and Method for the Treatment and Prevention of Cardiac, Pulmonary, Dermal, and Renal Fibrosis
4 May 23
The present disclosure relates to methods of treating or preventing various diseases or disorders, such as cardiac fibrosis, aortic fibrosis, pulmonary fibrosis, renal fibrosis, dermal fibrosis, and chronic kidney diseases, using cannabidiol derivatives or compositions thereof.
Alain ROLLAND, Eduardo MUÑOZ-BLANCO, Adela GARCIA-MARTIN, Carmen NAVARRETE
Filed: 8 Feb 21
Utility
Formulations of Cannabidiol Derivatives and Their Use as Modulators of Cannabinoid Receptor Type 2 (CB2)
16 Jun 22
Compositions, comprising the cannabidiol derivatives of Formula (I) in pharmaceutical formulations displaying increased bioavailability and solubility are described.
Alain ROLLAND, Eduardo Munoz BLANCO
Filed: 6 Feb 20
Utility
Cannabigerol Quinone Acid and Salts Thereof
10 Feb 22
Eduardo MUÑOZ BLANCO, Giovanni APPENDINO
Filed: 11 Dec 19
Utility
Cannabidiol Derivatives As Inhibitors of the Hif Prolyl Hydroxylases Activity
14 Oct 21
Cannabidiol quinol derivatives of Formula (I) and compositions comprising the same for use in the treatment of conditions that benefit from the inhibition of the HIF prolyl hydroxylases (PHDs) activity are described.
Eduardo MUÑOZ BLANCO, Carmen María NAVARRETE RUEDA, Cristina CRUZ TENO, María Luz BELLIDO CABELLO DE ALBA
Filed: 16 Feb 21
Utility
Cannabidiol Derivatives As Inhibitors of the Hif Prolyl Hydroxylases Activity
18 Mar 20
Cannabidiol quinol derivatives of Formula (I) and compositions comprising the same for use in the treatment of conditions that benefit from the inhibition of the HIF prolyl hydroxylases (PHDs) activity are described.
Eduardo MUÑOZ BLANCO, Carmen María NAVARRETE RUEDA, Cristina CRUZ TENO, María Luz BELLIDO CABELLO DE ALBA
Filed: 28 Mar 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first